Participants
| Role | Name | HCID | Charge |
|---|
| Reactant | Triethylamine | HCID 8471 | — |
| Reactant | 1-Methylpiperazine | HCID 53167 | — |
| Reactant | Methanaminium, N-((dimethylamino)(3H-1,2,3-triazolo(4,5-b)pyridin-3-yloxy)methylene)-N-methyl-, hexafluorophosphate(1-) (1:1) | HCID 9886157 | — |
| Reactant | HCID 71254842 | HCID 71254842 | — |
| Solvent | Dimethylformamide | HCID 6228 | — |
| Solvent | Ethyl Acetate | HCID 8857 | — |
| Product | HCID 71254937 | HCID 71254937 | — |
Reaction Steps
To a solution of 4-((2R,3R)-3-hydroxy-5,7-dimethoxychroman-2-yl)-2-methoxybenzoic acid (20 mg, 0.08 mmol) and triethylamine (22 μL, 0.16 mmol) in DMF (1 mL) was added HATU (38 mg, 0.1 mmol). The mixture was stirred for 0.5 hr and N-methylpiperazine (20 μL, 0.16 mmol) was added and the reaction was stirred for 12 hr. The mixture was diluted with ethyl acetate, washed with sat. sodium carbonate and brine, dried over sodium sulfate, and concentrated. The crude product was purified by preparative reverse phase HPLC using a gradient of 5% to 30% acetonitrile/(0.2% formic acid/water) over 10 min, analyzing at 280 nm. The appropriate fractions were frozen and lyophilized to give (4-((2R,3R)-3-hydroxy-5,7-dimethoxychroman-2-yl)-2 methoxyphenyl)(4-methylpiperazin-1-yl)methanone.
Provenance & Evidence
| DOI | 10.6084/m9.figshare.5104873.v1 |
|---|
| Patent number | US09187448B2 |
|---|
| Source dataset | uspto-grants-2015_11 |
|---|
| ORD ID | ord-693047bf0829425caf65aab4d01631eb |
|---|
| Source note | uspto-grants-2015_11 |
|---|